In this piece, you highlighted how cancer care still relies too heavily on trial and error, leaving many patients without a clear path to the right treatment. You introduced Functional Precision Medicine (FPM) as a breakthrough approach that tests live tumor cells, combines genomic insights, and uses AI to predict which therapies will work best for each individual. The article argues that this technology could transform oncology in 2026 by delivering faster, more effective, and more human-centered treatment decisions.